HomeEXECUTIVES

EXECUTIVES

Julie Sawyer Montgomery | Appointed Executive Vice President for Diagnostics at Danaher Corporation

Julie Sawyer Montgomery currently Vice President and Group Executive of Danaher's Clinical Diagnostics businesses, will become an executive officer of Danaher reporting to the President and Chief Executive Officer, Rainer Blair.

Mark Eisner MD, M.P.H. Appointed Chief Medical Officer at Vir Biotechnology

Mark Eisner MD comes from Sonoma Biotherapeutics, Inc., where he most recently held the position of CMO. In this role, he led all development functions which included biometrics, regulatory, clinical science, clinical operations, drug safety, and pharmacology.

Franck Mevellec Appointed Senior Director, Business Development at Asymchem

Franck Mevellec boasts a proven track record of success, having held key positions at industry leaders like Bayer Healthcare (R&D), Teva Pharmaceuticals (portfolio director), Minakem (BD director), and most recently, Seqens (global head of sales). He joins Asymchem with a focus on expanding the company’s footprint across Europe.

Veristat Appoints Dr Gabriela Rosu to Lead Growing Medical Affairs Team

Dr Gabriela Rosu is a seasoned professional with over twenty years of experience in scientific and clinical fields, having significantly contributed to the planning and execution of pivotal activities that have led to the approval and commercialization of groundbreaking therapies.

Sphere Fluidics Appoints Curtis Nicholson as Director of Sales, EMEA, to Support Accelerated Growth in Key Markets

Curtis Nicholson said “I’m thrilled to leverage my experience in strategic sales and driving innovation to take on this exciting role at Sphere Fluidics. I look forward to collaborating with the talented team and accelerating the adoption of our transformative solutions.”

Fiona Coats Appointed Chief Marketing Officer at Refeyn

Fiona Coats will bring with her a wealth of experience from over 25 years in the biotechnology sector. Her extensive background in science, combined with a proven track record of driving growth and innovation, positions her as a respected leader in the life science research market.

Simona Skerjanec Appointed to the BOD at Avidity Biosciences

Simona Skerjanec has led multiple research and development efforts that have resulted in regulatory approvals and launches of commercial therapies in therapeutic areas including neurology and cardiology in the U.S. and other countries.

Patrick Clysdale Joins Direct Sales Team at Herculite Products

Patrick Clysdale Patrick Clysdale will manage the company's Direct Sales team's southeastern region, which includes automotive, custom-engineered solutions, healthcare, agriculture, and tent and structure customers.

Dr Cheryl Pegus Elected to the Boston Scientific Board of Directors

Dr Cheryl Pegus has more than 25 years of clinical and business leadership experience, most recently serving as a partner at Morgan Health focused on improving the quality, affordability and equity of health care.